- Home
- XXII vs SXTP Comparison
XXII vs SXTP Comparison
Compare XXII & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- SXTP
- Stock Information
- Founded
- XXII 1998
- SXTP 2010
- Country
- XXII United States
- SXTP United States
- Employees
- XXII N/A
- SXTP N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- XXII Health Care
- SXTP Health Care
- Exchange
- XXII Nasdaq
- SXTP Nasdaq
- Market Cap
- XXII 2.8M
- SXTP 2.4M
- IPO Year
- XXII N/A
- SXTP 2023
- Fundamental
- Price
- XXII $1.30
- SXTP $1.88
- Analyst Decision
- XXII
- SXTP Hold
- Analyst Count
- XXII 0
- SXTP 1
- Target Price
- XXII N/A
- SXTP N/A
- AVG Volume (30 Days)
- XXII 52.8K
- SXTP 31.9K
- Earning Date
- XXII 03-20-2025
- SXTP 05-14-2025
- Dividend Yield
- XXII N/A
- SXTP N/A
- EPS Growth
- XXII N/A
- SXTP N/A
- EPS
- XXII N/A
- SXTP N/A
- Revenue
- XXII $24,382,000.00
- SXTP $681,345.00
- Revenue This Year
- XXII $45.16
- SXTP $147.16
- Revenue Next Year
- XXII $48.70
- SXTP $101.60
- P/E Ratio
- XXII N/A
- SXTP N/A
- Revenue Growth
- XXII N/A
- SXTP 168.70
- 52 Week Low
- XXII $1.24
- SXTP $1.41
- 52 Week High
- XXII $581.85
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- XXII 27.85
- SXTP 42.74
- Support Level
- XXII $1.32
- SXTP $1.72
- Resistance Level
- XXII $1.51
- SXTP $1.92
- Average True Range (ATR)
- XXII 0.15
- SXTP 0.18
- MACD
- XXII 0.05
- SXTP 0.07
- Stochastic Oscillator
- XXII 8.45
- SXTP 39.29
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.